Nectar Lifescience Ltd
company logo

Nectar Lifescience Ltd

Pharmaceuticals
Small Cap

-

- (0%)


Nectar Lifescience Ltd Performance

-

-

-

-


-

-

-

-

-

Nectar Lifescience Ltd Fundamentals

666.73Cr

135.14

0.62

0.75

0.22

-%

47.68

i buttonClick here to know more about Fundamentals

Nectar Lifescience Ltd Financials

Nectar Lifescience Ltd Financialsright-arrow

Nectar Lifescience Ltd Shareholding Pattern

Nectar Lifescience Ltd Delivery and Volume

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsu

Sanjiv Goyal

1995

NECLIFE

NameDesignation
Sanjiv GoyalChairman & Managing Director
Vijay J ShahDirector
Ajay SwaroopIndependent Director
Meena VermaNominee
S P SinghDirector
Rupinder TewariIndependent Director
Aryan GoyalExecutive Director
AnubhaCompany Sec. & Compli. Officer
Sunder LalCompany Secretary
Basant Kumar GoswamiDirector
Kuldip Kumar BhasinIndependent Director
Indu Pal KaurIndependent Director
Puneet SudDirector (Operation)
News and Events...

Similar Stocks

What's Trending

Nectar Lifescience Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Nectar Lifescience Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Nectar Lifescience Ltd's share price is ₹29.7 as of 2024-07-13.
Nectar Lifescience Ltd's P/E ratio is 135.14 times as of 2024-07-13.
Nectar Lifescience Ltd's most recent financial reports indicate a price-to-book ratio of 0.62, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Nectar Lifescience Ltd's market capitalization is ₹666.73 Cr as on 2024-07-13.
The current financial records of Nectar Lifescience Ltd show a -5.85% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Nectar Lifescience Ltd's most recent financial filings, the company has a total asset value of ₹1386.01, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Nectar Lifescience Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Nectar Lifescience Ltd's 52-week high and low as of 2024-07-13 are ₹30.22 and ₹29.6, respectively.